Bookmark and Share

2012 Divisional Bibliography

Peer Reviewed

  1. Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR, Weir MR, Feldman HI; CRIC Study Investigators. Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2012 Aug (2):250-61.
  2. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J, Wier WG. How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol. 2012 02:H1031-49.
  3. Cardone, R.A., Greco, M.R., Rucci, N., Capulli, M., Weinman, E.J., Busco, G., Bellizzi, A., Casavola, V., Antelmi, E., Paradiso, A., Teti, A., Reshkin, S.J.: NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains. Mol. Biol. Cell. 11:2028-2040, 2012.
  4. Carey RM, Schoeffel CD, Gildea JJ, Jones JE, McGrath HE, Gordon LN, Park MJ, Sobota RS, Underwood PC, Williams J, Sun B, Raby B, Lasky-Su J, Hopkins PN, Adler GK, Williams SM, Jose PA, Felder RA. Salt Sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension. 2012;60:1359-66, 2012.
  5. Carpenter MA, Weir MR, Adey DB, House AA, Bostom AG, Kusek JW. Inadequacy of cardiovascular risk factor management in chronic kidney transplantation – evidence from the FAVORIT study. Clin Transplant. 2012 Jul;26(4):E438-46.
  6. Chasman DI, Fuchsberger C, Pattaro C, Teumer A, Böger CA,……. Parsa A (listed as one of senior authors, total of 163 authors), Bochud M, Heid IM, Kao WH, Fox CS, Köttgen A.  Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet. 2012 Dec 15;21(24):5329-5343.
  7. Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE, Armando I, Jose PA. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension. 2012;59:446-52. 
  8. Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA. Decline in renal functioning is associated with longitudinal decline in global cognitive functioning abstract reasoning and verbal memory. Nephrol Dial Transplant. 2012 Nov 18.
  9. deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, Wolf M, Gaggin H, Januzzi J. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012 Sep;58(9): 1342-51.
  10. deFilippi CR, de Lemos JA, Tkaczuk AT, Christenson RH, Carnethon MR, Siscovick DS, Gottdiener JS, Seliger SL. J Am Coll Cardiol. 2012 Dec 18; 60(24):2539-47.
  11. Diamantidis CJ, Seliger SL, Zhan M, Walker LD, Rattinger GB, Hsu VD, Fink JC.  A varying patient safety profile between blacks and non-blacks with decreased estimated GFR. Am J Kidney Dis, 2012 60:47-53
  12. Diamantidis CJ, Zuckerman M, Fink W, Hu P, Yang S, Fink JC. Usability of a chronic kidney disease educational Web site targeted to patients and their family members. Clin J Am Soc Nephrol, 2012, 7(10):1553-60
  13. Diamantidis CJ, Zuckerman M, Fink W, Aggarwal S, Prakash D, Fink JC.  Usability testing and acceptance of a multi-platform IT Medication Inquiry System (MIS) in chronic kidney disease (CKD). Am J Kidney Dis (ePub), 2012
  14. Di Sole F, Vadnagara K, Moe OW, Babich V. Calcineurin homologous protein: A multi-functional Ca2+-binding protein family. Am J Physiol Renal Physiol. 2012;303:F165-79.
  15. Ellingson KD, Palekar RS, Lucero CA, Kurkjian KM, Chai SJ, Schlossberg DS, Vincenti DM, Fink JC, Davies-Cole JO, Magri JM, Arduino MJ, Patel PR. Vascular access hemorrhages contribute to deaths among hemodialysis patients.  Kidney Int, 2012, ePub.
  16. Ellis JW, Chen MH, Foster MC, Liu CT, Larson MG, de Boer I, Köttgen A, Parsa A, Bochud M, Böger CA, Kao L, Fox CS, O'Seaghdha CM; CKDGen Consortium; CARe Renal Consortium. Validated SNPs for eGFR and their associations with albuminuria. Hum Mol Genet. 2012 Jul 15;21(14):3293-8.
  17. Fayek SA, Keenan J, Haririan A, Cooper M, Barth RN, Schweitzer E, Bromberg JS, Bartlett ST, Philosophe B. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation. 2012 Feb 15;93(3):304-8.
  18. Fink JC, Joy MS, St Peter WL, Wahba IM, Finding a common language for patient safety in chronic kidney disease. Clin J Am Soc Nephrol. 2012, 7:689-695.
  19. Gildea JJ, Wang X, Shah N, Tran H, Spinosa M, Van Sciver R, Sasaki M, Yatabe J, Carey RM, Jose PA, Felder RA. Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension. 2012;60:396-403.
  20. Girardi AC, Di Sole F. Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction. Review. Am J Physiol Cell Physiol. 2012; 302:C1569-87.
  21. Giral, H., Cranston, D., Lanzano, L., Caldas, Y., Sutherland, E., Rachelson, J., Dobrinskikh, E., Doctor, R.R., Weinman, E.J., Gratton, E., and Levi, M.: NHE3 Regulatory Factor 1 (NHERF1) Modulates Intestinal Na-dependent Phosphate Transporter (NaPi-2b) Expression in Apical Microvilli J Biol Chem. 287:35047-35056, 2012.
  22. Greathouse MK and Weir MR. The Role of ARBs Alone or with HCTZ in the Treatment of Hypertension and Prevention of Cardiovascular and Renal Complications. Postgrad Med. 2012 Mar;124(2):40-52.
  23. Grunwald JE, Alexander J, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker C, McWilliams K, Lo JC, Go A, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D, Jaar BG; for the CRIC Study Group. Retinopathy and Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort (CRIC) Study. Arch Ophthalmol. 2012 Sep 1;130(9):1136-1144
  24. Halterman JA, Kwon HM, Leitinger N, Wamhoff BR. NFAT5 expression in bone marrow-derived cells enhances atherosclerosis and drives macrophage migration. Frontiers in Vascular Physiology 3: 313, 2012
  25. Huang H, Ren H, Chen C, Wang X, Yang J, Han Y, He D, Zhou L, Asico LD, Jose PA, Zeng C. D3 dopamine receptor regulation of D5  receptor expression and function in renal proximal tubule cells. Hypertens Res. 2012;35:639-47.
  26. Jiang X, Wang W, Ning B, Liu X, Gong J, Gan F, Gao X, Zhang L, Jose PA, Qin C, Yang Z. Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens. 2013;35:74-8.
  27. Jones H, Talwar M, Nogueira JM, Ugarte R, Cangro C, Rasheed H, Klassen DK, Weir MR, Haririan A. Anemia After Kidney Transplantation: Its Prevalence, Risk Factors, and Independent Association with Graft and Patient Survival: A Time-Varying Analysis. Transplantation. 2012 May 15;93(9):923-8.
  28. Jones JE, Jurgens JA, Evans SA, Ennis RC, Villar VA, Jose PA. Mechanisms of fetal programming in hypertension. Intl J Pediatr. 2012; ID 584831, 2012.
  29. Karadsheh F, Weir MR. Thiazide-like Diuretics: An opportunity to Reduce Blood Pressure in Patients with Advanced Kidney Disease. Curr Hypertens Rep. 2012 Oct;14(5):416-20.
  30. Konkalmatt PR, Wang F, Xu Y, Piras BA, Beyers RJ, O’Conner DM, Annex BH, Hossack JA, French BA. Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling. J Gene Med. 2012, 14:609-20.
  31. Köttgen A, Albrecht E, Teumer A, ….Parsa A (middle author) et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2012 Dec 23. Epub ahead of print
  32. Lai EY, Luo Z, Onozato ML, Rudolph EH, Solis G, Jose PA, Wellstein A, Aslam S, Quinn MT, Griendling KK, Le TH, Li P, Palm F, Welch WJ, Wilcox CS. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol. 2012;303:F64-F74.
  33. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, Carithers RL, Ragosta M, Bolton K, Auerbach AD, Eagle KA; on behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease. Circulation. 2012 Jul 31; 126 (5):617-663.
  34. Liu T, Jose PA. Gastrin Induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but akt-independent pathway in renal proximal tubule cells derived from a normotensive male human. Endocrinology. 2012 Dec 28.
  35. McArdle PF, Whitcomb BW, Tanner K, Mitchell BD, Shuldiner AR, Parsa A.  Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference.  BMC Cardiovasc Disord. 2012 Mar 14;12:16.
  36. Mohanlol V, Parsa A, Weir MR. Role of dietary therapies in the prevention and treatment of hypertension. Nat Rev Nephrol. 2012 May 15;8(7):413-22.
  37. Mohanlal V, Haririan A, Weinman EJ. Bradycardia without "classical" EKG changes in hyperkalemic hemodialysis patients. Clin Nephrol. 2012 Jul 12. [Epub ahead of print]
  38. Onukwugha E, Saunders E, Mullins CD, Pradel FG, Zuckerman M, Loh FE, Weir MR. A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting. BMJ Open. 2012 Jul 30;2(4).
  39. Nesbitt SD, Shojaee A, Maa J-F, and Weir MR. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study). J Human Hypertens. 2012; 1-8.
  40. Pallone TL, Edwards A, Mattson DL. Renal Medullary Circulation. Compr Physiol 2012, 2: 97-140. doi: 10.1002/cphy.c100036
  41. Parsa A, Brown E, Weir MR, Fink JC, Shuldiner AR, Mitchell BD, McArdle PF. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int. 2012 Mar;81(5):502-7.
  42. Pattaro C, Köttgen A, Teumer A, Garnaas M, Böger CA, …………, Parsa A (listed as one of senior authors out of total of 162 authors), Bochud M, Heid IM, Goessling W, Chasman DI, Kao WH, Fox CS. Genome-wide association and functional follow-up reveals new loci for kidney function.  PLoS 2012;8(3):e1002584. Epub 2012 Mar 29.
  43. Patel K, Diamantidis C, Zhan M, Hsu VD, Walker LD, Gardner J, Weir MR, Fink JC. Influence of Creatinine versus Glomerular Filtration Rate on Non-Steroidal Anti-Inflammatory Drug Prescriptions in Chronic Kidney Disease. Am J Nephrol. 2012; 36(1): 19-26.
  44. Kalantari K, Seliger S. Stroke symptoms signal worse outcomes in patients with end-stage renal disease. Neurology. 2012 Sep 4;79(10):960-1.
  45. Khurana S, Raina H, Pappas V, Raufman J-P, Pallone TL. Effects of Deoxycholylglycine, a Conjugated Secondary Bile Acid, on Myogenic Tone and Agonist-Induced Contraction in Rat Resistance Arteries PLoS ONE 2012;7(2):e32006.
  46. Kop WJ, Gottdiener JS, deFilippi CR, Barasch E, Seliger SL, Jenney NS, Christenson RH. Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. Circ Heart Fail. 2012 Jul 1;5(4):406-13.
  47. Krum H, Swergold G, Gammaitoni A, Peloso PM, Smugar SS, Curtis SP, Brater DC, Wang H, Kaur A, Laine L, Weir MR, Cannon CP. Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs. Cardiovasc Ther. 2012 Dec;30(6):342-50.
  48. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, Carithers RL, Ragosta M, Bolton K, Auerbach AD, Eagle KA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012 Jul 31, 60(5):434-80.
  49. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, Carithers RL, Ragosta M, Bolton K, Auerbach AD, Eagle KA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease; American Heart Association; American College Foundation. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2012 Jul 31;126(5):617-63.
  50. Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B. Am J Kidney Dis. 2012 Dec;60(6):912-21.
  51. Sanada H, Yokokawa H, Yoneda M, Yatabe J, Yatabe MS, Williams SM, Felder RA, Jose pa. High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med. 2012;51;1821-6.
  52. Schleichert RA, Seliger SL, Zhan M, Gaspari AA. Nephrogenic systemic fibrosis and diabetes mellitus. Arch Dermatol. 2012 Feb; 148(2):255-7.
  53. Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER 3rd, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, Anderson CA; Chronic Renal Insufficiency Cohort (CRIC) Study Group. J Ren Nutr. 2012 Jul;22 (4):379-388.
  54. Seliger SL. Physical activity in ESRD: Time to Get Moving. Clin J Am Soc Nephrol. 2012 Dec;7(12):1927-9.
  55. Semba RD, Fink JC, Sun K, Cappola AR, Dalal M, Crasto C, Ferrucci L, Fried LP.  Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women. Clin J Am Soc Nephrol. 2012;7:85-91.
  56. Tlaxca JL, Rychak JJ, Ernst PB, Konkalmatt PR, Shevchenko TI, Pizzaro TT, Rivera-Nieves J, Klibanov AL, Lawrence MB. Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease. J Control Release. 2012,165:216-225.
  57. Tuchman S, Asico LD, Escano C, Bobb DA, Ray PE. Development of an animal model of nephrocalcinosis via selective dietary sodium and chloride depletion. Pediatr Res. 2012 Nov 22[Epub ahead of print].
  58. Van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, Radhakrishnan A, Tan ST, Voss K, Weichenberger CX, Albers CA, Al-Hussani A, Asselbergs FW, Ciullo M, Danjou F, Dina C, Esko T, Evans DM, Franke L, Gögele M, Hartiala J, Hersch M, Holm H, Hottenga JJ, Kanoni S, Kleber ME, Lagou V, Langenberg C, Lopez LM, Lyytikäinen LP, Melander O, Murgia F, Nolte IM, O'Reilly PF, Padmanabhan S, Parsa A et al.  Seventy-five genetic loci influencing the human red blood cell. Nature. 2012 Dec 20;492(7429):369-75.
  59. Villar VA, Armando I, Sanada H, Frazer LC, Russo CM, Notario PM, Lee H, Comisky L, Russell HA, Yang Y, Jurgens JA, Jose PA, Jones JE. Novel role of sorting nexin 5 in renal D1 dopamine receptor trafficking and function: implications for hypertension. FASEB J. 2012 Nov 29. [Epub ahead of print]
  60. Villar VA, Jones JE, Armando I, Asico LD, Escano CS Jr, Lee H, Wang X, Yang Y, Pascua-Crusan AM, Palmes-Saloma CP, Felder RA, Jose PA. Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice. J Biol Chem. 2012 Nov 14. [Epub ahead of print]
  61. Wang Y, Han Y, Yang J, Wang Z, Liu L, Wang W, Zhou L, Wang D, Tan X, Fu C, Jose PA, Zeng C. Relaxant effect of all-trans retinoic acid via NO-sGC-cGMP pathway and calcium-activated potassium channels in rat mesenteric artery. Am J Physiol Heart Circ Physiol. 2012 Nov 2. [Epub ahead of print]
  62. Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velazquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet. 2012 Dec 5. S0140-6736(12)61343-9.
  63. Weinman, E.J., and Lederer, E.D: PTH-mediated inhibition of renal phosphate transport. Exp. Cell Res. 318:1027-1032, 2012.
  64. Weinman, E.J., and Lederer, E.D: NHERF-1 and the regulation of renal phosphate reabsorption; a tale of three hormones. Am. J. Physiol. Renal Physiology 303:F321-F327, 2012
  65. Weir MR, Bakris GL, Weber MA, Dahlof B, Devereux RB, Kjeldsen SE, Pitt B, Wright JT, Kelly RY, Hua TA, Hester RA, Velazquez E, Jamerson KA. Renal Outcomes in hypertensive Black patients at high cardiovascular risk. Kidney Int. 2012 Mar;81(6):568-76.
  66. Weir MR, Agarwal R. Thiazide and thiazide-like diuretics: perspectives on individualization of drug and dose based on therapeutic index. Hypertension. 2012 Jun;59(6):1089-90.
  67. Weir MR. Improving the estimating equation for GFR-a clinical perspective. N Engl J Med. 2012 Jul 5;367 (1):75-6.
  68. Weir MR, Drachenberg CB. A 72-year-old woman with several months of weight loss and generalized weakness. Am J Med Sci. 2012 Aug; 344(2):142-5.
  69. Weir MR, Townsend RR, Fink JC, Teal V, Sozio SM, Anderson CA, Appel LJ, Turban S, Chen J, He J, Litbarg N, Ojo A, Rahman M, Rosen L, Steigerwalt S, Strauss L, Joffee MM. Urinary Sodium Is a Potent Correlate of Proteinuria: Lessons from the Chronic Renal Insufficiency Cohort Study. Am J Nephrol. 2012 Oct 12; 36(5):397-404.
  70. Weir MR. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? con position. J Am Soc Hypertens. 2012 Nov/Dec; 6(6):443-447.
  71. Weir MR, Bartlett ST, Drachenberg CB. Eosinophilia as an early indicator of pancreatic allograft rejection. Clin Transplant. 2012 Mar-Apr;26(2):238-41.
  72. Williams AW, Dwyer A, Eddy AA, Fink JC, Jaber BL, Linas S et al, Critical and Honest Conversations: The Evidence Behind the "Choosing Wisely" Campaign Recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol, 2012, 82(6):686-92
  73. Yang YR, Cho JH, Chang JS, Kwon HM, Jang HJ, Ryu SH, Suh PG. Diverse cellular and physiological roles of phospholipase C-γ1. Advances in Enzyme Regulation 52: 138-151, 2012.
  74. Yang J, Chen C, Ren H, Han Y, He D, Zhou L, Hopfer U, Jose PA, Zeng C. Angiotensin II AT2 receptor decreases AT1 receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J Hypertens. 2012;30:1176-84.
  75. Yang Y, Zhang Y, Cuevas S, Escano C, Villar VA, Asico L, Yu P, Grandy DK, Felder RA, Armando I, Jose PA. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med. 2012;53:437-46
  76. Yatabe J, Yatabe MS, Yoneda M, Felder RA, Jose PA, Sanada H. Hypertension-related gene polymorphisms of G-protein-coupled receptor kinase 4 are associated with NT-proBNP concentration in normotensive healthy adults .Int J Hypertens. 2012:806810.
  77. Zhang Y, Cuevas S, Asico LD, Escano C, Yang Y, Pascua AM, Wang X, Jones JE, Grandy D, Eisner G, Jose PA, Armando I. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One. 2012;7:e38745.

Book Chapters

  1. Armando I, Jose PA. Hypertension. ACP Clinical Genetics. Murray M, Babyatsky M, Giovanni M. McGraw-Hill
  2. Brown EM, Salzberg DJ, and Weir MR.  Renal Consequences of Prostaglandin Inhibition in Heart Failure. In: The Kidney in Heart Failure. George L. Bakris, Editor. Springer. 2012; 117-126
  3. Weir MR, Hanes D, Klassen DK.  Antihypertensive Drugs.  In: Brenner and Rector’s The Kidney. 9th ed. Brenner BM, Ed.  Saunders, Philadelphia 2012; 1824-1867: chap 49.
  4. Pallone TL, Khurana S, and C Cao. Calcium channels: voltage gated structure and function (CACNA). Encyclopedia of signaling molecules. Part 23 pp 1984-1992. 2012 Springer Verlag. S Choi editor